Morningstar Logo

Welcome!

  • About Morningstar >
  • Logout
  • Login
  • Subscribe
  • Register
  • Premium
  • Join Membership
  • Home
  • Portfolio
  • Stocks
  • Bonds
  • Funds
  • ETFs
  • Markets
  • Tools
  • Advisors
  • Personal Finance
  • Discuss

    News, Alerts, and Opinions

    Headline Source Date
    Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018 GlobeNewswire 04/18/18 EDT
    Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis GlobeNewswire 04/16/18 EDT
    Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018 GlobeNewswire 04/04/18 EDT
    Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference GlobeNewswire 04/02/18 EDT
    Mid-Afternoon Market Update: NASDAQ Up 2%; Movado Shares Surge On Earnings Beat Benzinga 03/29/18 EDT
    Mid-Day Market Update: Dow Rises Over 1%; Zosano Pharma Shares Plummet Benzinga 03/29/18 EDT
    Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update GlobeNewswire 03/29/18 EDT

    Corrections  Help  Advertising Opportunities  Licensing  Topics  MorningstarAdvisor  Glossary  RSS  Store  Affiliate  Careers  Company Site

    • International Sites
    • Australia
    • Canada
    • China
    • France
    • Germany
    • Hong Kong
    • Italy
    • The Netherlands
    • Norway
    • Spain
    • U.K.
    • Switzerland
    • India
    • Finland

    Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

    © Copyright 2016 Morningstar, Inc. All rights reserved. Please read our Terms of Use and Privacy Policy. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.